Senate Panel Targets 'Clever' Pharma Pricing
By Mark Payne · October 29, 2024, 4:20 PM EDT
The Senate Judiciary Committee on Tuesday railed against drugmakers and pharmacy benefit managers for allegedly causing the high cost of prescription drugs, arguing that "Big Pharma" has used anticompetitive tactics through...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login